Imran Arif, MD
Interventional Cardiology · Cincinnati, OHNPI 1154380970
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.9%. Reporting peaked in 2019 at $4,168 and has fallen 68.4% since, to $1,319 in 2025.
Across 194 payments — averaging $61.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- CSL Behring$2K
- Edwards Lifesciences$2K
- W. L. Gore & Associates, Inc.$1K
- AOP Health US, LLC$761
- Medtronic$640
- plus $3K from 28 others
Across 83 payments — averaging $1386.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$61K
- Abbott$54K
What the payments were for
- Travel & lodging$5,15543%
- Food & beverage$6,67456%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 53 | $2,363 |
| CSL Behring | 12 | $2,203 |
| Edwards Lifesciences | 17 | $1,738 |
| W. L. Gore & Associates, Inc. | 9 | $1,401 |
| AOP Health US, LLC | 2 | $761 |
| Medtronic(2 entities) | 30 | $640 |
| Inari Medical, Inc. | 5 | $518 |
| Boston Scientific | 13 | $276 |
| Siemens Medical Solutions USA, Inc. | 3 | $223 |
| Abiomed | 4 | $186 |
| Angiodynamics, Inc. | 4 | $165 |
| Shockwave Medical, Inc | 1 | $143 |
| Livanova USA, Inc. | 1 | $109 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $109 |
| Novartis | 6 | $108 |
| Amgen | 2 | $96 |
| Bard Peripheral Vascular, Inc. | 1 | $84 |
| Penumbra, Inc. | 1 | $81 |
| Sanofi | 1 | $80 |
| Imperative Care, Inc | 1 | $77 |
| Akcea Therapeutics, Inc. | 1 | $72 |
| Medical Device Business Services, Inc. | 3 | $68 |
| Chiesi USA, Inc. | 4 | $67 |
| Cardiva Medical, Inc. | 3 | $63 |
| Stryker | 1 | $50 |
| ZOLL Circulation Inc | 1 | $30 |
| Boehringer Ingelheim | 1 | $24 |
| Endotronix, Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Bayer | 1 | $18 |
| Thrombolex, Inc. | 1 | $17 |
| Biotronik Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rapiblyk$1,522
- CARDIOFORM Septal Occluder$1,288
- MitraClip System$1,184
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,046
- CT THROMBECTOMY SYSTEM KIT$373
- FLOWTRIEVER CATHETER, S$373
- COREVALVE EVOLUT R$159
- CoreValve Evolut$144
- Vascular Lithotripsy$143
- Xience Sierra Coronary Stent$136
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$132
- AMPLATZER TALISMAN$125
- Impella$121
- Diamondback Coronary$117
- LifeSPARC$109
- CorPath GRX$107
- Mitra Clip system$102
- ACUSON SC2000 Diagnostic Ultrasound System$102
How this compares
$11,854 in reported general payments places this provider in the 65th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 95 | $120,252 |
| EliquisApixaban | 137 | $97,242 |
| JardianceEmpagliflozin | 28 | $38,454 |
| Repatha SureclickEvolocumab | 37 | $32,422 |
| VascepaIcosapent Ethyl | 17 | $13,412 |
| Metoprolol Succinate | 280 | $2,922 |
| Atorvastatin Calcium | 307 | $2,222 |
| Ranolazine ErRanolazine | 21 | $1,730 |
| Rosuvastatin Calcium | 159 | $1,658 |
| Carvedilol | 151 | $1,355 |
| ClopidogrelClopidogrel Bisulfate | 143 | $1,302 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 76 | $1,021 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $844 |
| Nifedipine ErNifedipine | 29 | $828 |
| Losartan Potassium | 137 | $767 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $108 | $120,25295 claims |
| Boehringer IngelheimJardiance | $24 | $38,45428 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Cincinnati
- Timothy HenryCincinnati$605K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
- Joseph ChooCincinnati$224K
- Dean KereiakesCincinnati$139K
- Ian SarembockCincinnati$98K
- Puvi SeshiahCincinnati$81K
- Raviteja GuddetiCincinnati$68K
- Satya ShreenivasCincinnati$47K
- Amer SayedCincinnati$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.